Skip to main content

Indian scientists resurrect World War-era drug to fight malaria ( downtoearth)

A neglected and old anti-parasitic drug used during the World War II is emerging as a new weapon in the fight against malaria as malaria parasite becomes resistant to currently available drugs.

A group of Indian researchers have resurrected acriflavine or ACF which was used as an anti-parasite drug in the last century, and have found it to be effective against malaria parasite. Now they are working to make this molecule more effective using nanotechnology.

Researchers at the Special Centre for Molecular Medicine at Jawaharlal Nehru University (JNU) have got a patent for antimalarial properties of ACF. They have now joined hands with scientists at the National Institute of Immunology (NII) to develop a nano-formulation of the dug and to study its potential in animal models. The Department of Biotechnology (DBT) is funding this joint effort.

ACF was previously used as a trypanocidal agent against a range of infections during World War II. But due to preferential use of chloroquine for treatment of malaria, its antimalarial activity was never investigated. “It was used as an antibacterial and anti-parasitical agent but it was not known as antimalarial agent. We have found that it is effective as an antimalarial molecule also,” said Prof Suman Dhar of JNU. “We believe nanoformulation of ACF will help release the molecule slowly into the host. This will increase its stability, and it will be then conjugated with specific antibodies to make it more specific.”

The researchers have already shown that ACF inhibits the growth of both chloroquine-sensitive and chloroquine-resistant strains of human malarial parasite, Plasmodium falciparum. It was also found to clear malarial infection from bloodstreams of mice infected with Plasmodium berghei. In addition, they have found that ACF is preferentially accumulated in the parasitized red blood cells.

Chloroquine and pyrimethamine, which were used as primary chemotherapeutic drugs, are of little use now since the parasite has developed resistance to them. Though there is a decline in global burden of malaria continues to be a major health problem in many countries. Recent reports of resistance to artemisinin, the only effective antimalarial drug at present, are causing concern among health agencies globally.

The team of researchers includes Prof Suman Dhar from Special Center for Molecular Medicine at JNU; Dr Jaydeep Bhattacharya and Dr Deepak Gaur from School of Biotechnology at JNU; and Dr Agam P. Singh from NII, New Delhi. (Indian Science Wire)

Comments

Popular posts from this blog

Khar’s experimentation with Himalayan nettle brings recognition (downtoearth)

Nature never fails to surprise us. In many parts of the world, natural resources are the only source of livelihood opportunities available to people. They can be in the form of wild shrubs like Daphne papyracea and Daphne bholua (paper plant) that are used to make paper or Gossypium spp (cotton) that forms the backbone of the textile industry.

Nothing can compete with the dynamism of biological resources. Recently, Girardinia diversifolia (Himalayan nettle), a fibre-yielding plant, has become an important livelihood option for people living in the remote mountainous villages of the Hindu Kush Himalaya.

There is a community in Khar, a hamlet in Darchula district in far-western Nepal, which produces fabrics from Himalayan nettle. The fabric and the things made from it are sold in local as well as national and international markets as high-end products.

A Himalayan nettle value chain development initiative implemented by the Kailash Sacred Landscape Conservation and Development Initiati…

SC asks Centre to strike a balance on Rohingya issue (.hindu)

Supreme Court orally indicates that the government should not deport Rohingya “now” as the Centre prevails over it to not record any such views in its formal order, citing “international ramifications”.

The Supreme Court on Friday came close to ordering the government not to deport the Rohingya.

It finally settled on merely observing that a balance should be struck between humanitarian concern for the community and the country's national security and economic interests.

The court was hearing a bunch of petitions, one filed by persons within the Rohingya community, against a proposed move to deport over 40,000 Rohingya refugees. A three-judge Bench, led by Chief Justice of India Dipak Misra, began by orally indicating that the government should not deport Rohingya “now”, but the government prevailed on the court to not pass any formal order, citing “international ramifications”. With this, the status quo continues even though the court gave the community liberty to approach it in …

New passport application rules add options for single parents, sadhus(Livemint)

Sadhus/sanyasis (Hindu ascetics) can apply for a passport with the name of their spiritual guru in lieu of their biological parents.
 New Delhi: Acknowledging a changing social milieu and its reflection in paperwork, the ministry of external affairs on Friday unveiled a series of changes in the passport application process.

The online passport application form now requires the applicant to provide the name of only one parent as opposed to both in order to enable those with single parents to apply for passports.

This comes on the heel of reports over the past two years of passport offices insisting on the father’s name in the form even if the mother is a single parent.

“A three-member committee comprising of officials of the ministry of external affairs and the ministry of women and child development was constituted to examine various issues pertaining to passport applications. These pertain to single parents, parents with adopted children and instances where they did not want the in…